carpal tunnel syndrome. Carpal tunnel syndrome, unspecified upper limb
Conditions
Interventions
Intervention 1: Intervention group: For the first group, in addition to the splint, one session of 40 mg of methylprednisolone injection is performed in a slightly proximal area to the distal crease b
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
25 Years to 65 Years
Inclusion criteria
Inclusion criteria: The patients have mild to moderate carpal tunnel syndrome by electrodiagnostic evaluation.
Exclusion criteria
Exclusion criteria: The patients with related underling diseases such as pregnancy, diabetes mellitus, hypothyriodism, rheumatoid arthritis, inflammatory arthropathy, polyneuropathy, alcoholism, infections, cervical disc pathology, trauma and surgery Contraindication for needling, such as bleeding tendency, local infection, needle phobia or history of needle shock Allergy to methylprednisolone Dissatisfaction with participating in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptom severity scale and functional status scale. Timepoint: Measurement of all variables at the beginning of the study (before the intervention) and one month after the intervention. Method of measurement: Boston carpal tunnel syndrome questionnaire.;Intensity of pain with Visual Analogue Scale. Timepoint: Measurement of all variables at the beginning of the study (before the intervention) and one month after the intervention. Method of measurement: Visual Analogue Scale.;Median nerve sensory amplitude. Timepoint: Measurement of all variables at the beginning of the study (before the intervention) and one month after the intervention. Method of measurement: Electrodiagnostic measurement.;Median nerve motor amplitude. Timepoint: Measurement of all variables at the beginning of the study (before the intervention) and one month after the intervention. Method of measurement: Electrodiagnostic measurement.;Sensory velocity of median nerve at wrist. Timepoint: Measurement of all variables at the beginning of the study (before the intervention) and one month after the intervention. Method of measurement: Electrodiagnostic measurement.;Median nerve sensory latency. Timepoint: Measurement of all variables at the beginning of the study (before the intervention) and one month after the intervention. Method of measurement: Electrodiagnostic measurement.;Median nerve motor latency. Timepoint: Measurement of all variables at the beginning of the study (before the intervention) and one month after the intervention. Method of measurement: Electrodiagnostic measurement. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Babaeian
Shiraz University of Medical Sciences
Outcome results
None listed